GO
Loading...

Glaxo to Buy Human Genome Sciences

Monday, 16 Jul 2012 | 10:26 AM ET

CNBC's David Faber reports Glaxo will buy Human Genome for $14.24 per share, and TPG acquires generic drugmaker Par Pharma.